Home>Topics>Stocks>Auxilium Pharmaceuticals

Auxilium Pharmaceuticals AUXL

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. 2nd Half Of 2014 Biotechnology Catalysts - Part 4

      Headlines

      Sun, 17 Aug 2014

      By Alexander Maxwell : Having previously updated the investment community in part 3 of my Biotechnology Catalysts series, the purpose of this article is to help give investors an idea of the upcoming biotechnology catalysts through the end of September. It can be hard for investors to be able to ...

    2. Update: BioSpecifics Technologies Earnings

      Headlines

      Fri, 15 Aug 2014

      and controls patents and patent applications for XIAFLEX and is entitled to get royalties until 2028 from Auxilium (NASDAQ: AUXL ) for Dupuytren's Contracture, Peyronie's Disease, Frozen Shoulder and Cellulite. Thomas L. Wegman, President of BioSpecifics

    3. Update: Auxilium Pharmaceuticals Earnings

      Headlines

      Fri, 15 Aug 2014

      By Andy Batts : Auxilium Pharmaceuticals (NASDAQ: AUXL ) recently reported its second quarter 2014 financial results ..... excellent investing opportunity for long-term investors. AUXL data by YCharts The decline in Auxilium's second quarter

    4. Why Tax Inversions Won't Go Away

      Headlines

      Wed, 13 Aug 2014

      By Uncommon Profit Investor : Tax inversion frenzy Tax inversion is the method of lowering a US company's tax rate by acquiring a foreign company. As long as the shareholders of the foreign company being acquired own at least 20% of the shares of the combined company, the acquirer can take on the

    5. New finance chief at Auxilium Pharma

      Headlines

      Mon, 11 Aug 2014

      Auxilium Pharmaceuticals (NASDAQ: AUXL ) appoints Andrew Saik as CFO effective August 18, 2014. He joins the firm from Endo Health Solutions where he was SVP, Finance and Treasurer. Post your comment!

    6. Auxilium Pharmaceuticals' ( AUXL ) CEO Adrian Adams on Q2 2014 Results - Earnings Call Transcript

      Headlines

      Thu, 7 Aug 2014

      Auxilium Pharmaceuticals (NASDAQ: AUXL ) Q2 2014 Earnings Call August 07, 2014 8:30 am ET ..... Good day, ladies and gentlemen, and welcome to the Q2 Auxilium Pharmaceuticals Incorporated Earnings Conference Complete Story »

    7. Auxilium Pharmaceuticals ( AUXL ) Q2 2014 Results - Earnings Call Webcast

      Headlines

      Thu, 7 Aug 2014

      The following audio is from a conference call that will begin on August 07, 2014 at 08:30 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen now Complete Story »

    8. Auxilium Pharma updates guidance after Q2 results

      Headlines

      Thu, 7 Aug 2014

      Auxilium Pharmaceuticals ( AUXL +2.6% ) Q2 results : Revenues: $83.0M (-17.4%); Operating Expenses: $110.2M (-14.5%); Operating Loss

    9. Auxilium Pharma posts bigger-than-expected quarterly loss

      Headlines

      Thu, 7 Aug 2014

      Aug 7 (Reuters) - Drugmaker Auxilium Pharmaceuticals posted a much bigger-than-expected quarterly loss, hurt by falling sales of testosterone gel Testim.

    10. Auxilium Pharmaceuticals misses by $0.23, misses on revenue

      Headlines

      Thu, 7 Aug 2014

      Auxilium Pharmaceuticals (NASDAQ: AUXL ): Q2 EPS of -$0.44 misses by $0.23 . Revenue of $83M (-17.4% Y/Y) misses by $5.52M . Press Release Post your comment!

    « Prev123Next »
    Content Partners